Atricure Inc. buy stratec
Start price
12.04.19
/
50%
€25.43
Target price
04.11.21
€66.00
Performance (%)
143.79%
End price
05.11.21
-
Summary
This prediction is currently being closed. The BUY prediction by stratec for Atricure Inc. has seen massive gains of 143.79%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atricure Inc. | - | - | - | - |
| iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
| iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
| iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
| iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
Comments by stratec for this prediction
In the thread Atricure Inc. diskutieren
stratec stimmt dem Sentiment von 'Sell' nicht zu
The stock got an Overweight rating with a $37 price target at JP Morgan. Morgan's analyst list three key reasons he likes the shares at current trading levels.
- The valuation is attractive and the name offers durable organic mid-teens top-line growth.
- Has a favorable view on the lack of competitors.
- Sees catalysts from COVERAGE data over the coming 1-year period.
Kursziel geändert auf 46,0
Kursziel geändert auf 66,0
In the thread Trading Atricure Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten